Filing Details
- Accession Number:
- 0001127602-14-032949
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-20 09:36:03
- Reporting Period:
- 2014-11-18
- Filing Date:
- 2014-11-20
- Accepted Time:
- 2014-11-20 09:36:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1224662 | A John Kraeutler | 3471 River Hills Drive Cincinnati OH 45244 | Chairman And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-18 | 10,500 | $7.28 | 284,261 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-18 | 10,500 | $16.20 | 273,761 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2014-11-18 | 10,500 | $0.00 | 10,500 | $7.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-12-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 673 | Indirect | Held in Meridian Savings & Investment Plan (401K) |
Footnotes
- Prices range from $16.20 per share to $16.23 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
- These options became fully vested in November 2008.
Billionaire Hedge Funds
